Elon Musk's brain-implant company Neuralink said it received approval from the Food and Drug Administration to begin human clinical trials.
Share:
More In Science
FDA Expected to Approve First CRISPR Gene-Editing Treatment
The Food and Drug Administration is expected to approve the first CRISPR gene-editing therapy.
Study Examines High Blood Pressure Among Couples
A new study examines the prevalence of high blood pressure among couples.
Study: Wasabi Linked to Memory Boost
A study out of Japan found that a little bit of wasabi can improve memory.
Study: Eye Scans Provide Insights Into Kidney Health
A new study reveals that 3D eye scans can reveal important clues about your kidney health.
Be Well: Weightless Full Body Workout Routine
Weightless Full Body Workout Routine
New Treatment for Obesity Hits Pharmacy Shelves
Eli Lilly launched Zepbound, the latest product to join the exploding market for weight loss medications.
Company Offering DNA Data Storage
A new storage drive is using DNA to store data for 100 and 50 years.
Surprise Eruption of Indonesia's Mount Marapi Volcano Kills Climbers
Rescuers searching the hazardous slopes of Indonesia’s Mount Marapi volcano found more bodies among the climbers caught by a surprise eruption two days ago, raising the number of confirmed and presumed dead to 23.
Flu Is on the Rise While RSV Infections May Be Peaking, U.S. Health Officials Say
Flu is picking up steam while RSV lung infections that can hit kids and older people hard may be peaking, U.S. health officials said.
